Financhill
Back

Insight Molecular Diagnostics 10K Form

Sell
30

IMDX
Insight Molecular Diagnostics

Last Price:
$2.94
Seasonality Move:
-2.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IMDX News And Ratings

See the #1 stock for the next 7 days that we like better than IMDX

IMDX Financial Statistics

Sales & Book Value

Annual Sales: $1.9M
Cash Flow: $-6.2M
Price / Cash Flow: 0
Annual Sales: $0.36
Price / Book: 7.92

Profitability

EPS (TTM): -3.53000
Net Income (TTM): $-58.2M
Gross Margin: $740K
Return on Equity: -693.81%
Return on Assets: -93.47%

Insight Molecular Diagnostics Earnings Forecast

Key Insight Molecular Diagnostics Financial Ratios

  • The Gross Profit Margin over the past 6 years for IMDX is 39.34%.
  • The Selling, General & Administrative Expenses for IMDX have been equal to 732.85% of Gross Profit Margin.
  • The Research & Development expenses have been 523.07% of Revenue.
  • The Net Earning history of IMDX is -3,225.04% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 4 years.

Insight Molecular Diagnostics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IMDX
Website: imdxinc.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.75
Quick Ratio: 3.57

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IMDX Technical Analysis vs Fundamental Analysis

Sell
30
Insight Molecular Diagnostics (IMDX) is a Sell

Is Insight Molecular Diagnostics a Buy or a Sell?